Kliniske studier sponset av Safe Save Medical Cell Sciences & Technology Co.,Ltd.
Totalt 6 resultater
-
Safe Save Medical Cell Sciences & Technology Co...UkjentADCTA for adjuvant immunterapi i standardbehandling av tilbakevendende glioblastoma multiforme (GBM)Glioblastoma MultiformeTaiwan
-
Beijing 302 HospitalBeijing GD Initiative Cell Therapy Technology Co., Ltd.; Chinese Academy...Har ikke rekruttert ennå
-
Beijing 302 HospitalBeijing GD Initiative Cell Therapy Technology Co., Ltd.; Chinese Academy...Har ikke rekruttert ennå
-
Beijing 302 HospitalCancer Institute and Hospital, Chinese Academy of Medical Sciences; Beijing...UkjentHepatocellulært karsinomKina
-
Institute of Hematology & Blood Diseases HospitalCancer Institute and Hospital, Chinese Academy of Medical Sciences; Beijing...RekrutteringNon-Hodgkins lymfom (NHL) | Perifert T-celle lymfom (PTCL)Kina
-
Institute of Hematology & Blood Diseases HospitalCancer Institute and Hospital, Chinese Academy of Medical Sciences; Beijing...UkjentNon-Hodgkins lymfom | Perifert T-celle lymfom | Tilbakefallende eller refraktær B-celle non-Hodgkins lymfom | Kronisk lymfoblastisk leukemiKina